Typicality: | 0.243 |
Saliency: | 0.340 |
in patients with ad | 6 | other |
as of december | 4 | temporal |
early phase | 2 | temporal |
trial → show → promising results | 14 |
trial → shown → promising results | 7 |
trial → produced → promising results | 4 |
negative | neutral | positive |
0.026 | 0.124 | 0.850 |
Raw frequency | 25 |
Normalized frequency | 0.340 |
Modifier score | 0.300 |
Perplexity | 72.931 |